HALEON PLC SPON ADS EACH REP 2 ORD SHS

Haleon Spon Ads Each Rep 2 Ord Shs (HLN) Stock

Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Haleon Spon Ads Each Rep 2 Ord Shs in July 2026.

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Haleon's stock, with a target price suggesting it may rise.

Above Average

Financial Health

Haleon is generating strong revenue and profit margins, indicating solid financial performance.

Below Average

Dividend

HALEON's projected dividend yield of 1.5% is modest, indicating limited dividend income. If you invested $1000 you would be paid $15 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Discover More Opportunities

ABBV

AbbVie

Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.

AZN

ASTRAZENECA PLC

AstraZeneca is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines.

AMGN

AMGEN INC

Amgen is a global biotechnology company that focuses on discovering, developing and commercializing treatments for unmet medical needs.

Baskets Featuring HLN

Personal Care Stocks | Talc Lawsuit Impact on Market

Personal Care Stocks | Talc Lawsuit Impact on Market

A jury has ordered Johnson & Johnson to pay $40 million in a lawsuit linking its talc-based powder to ovarian cancer, adding to its significant legal challenges. This ongoing litigation creates an opportunity for competitors offering safer, talc-free personal care alternatives to gain market share.

Published: 13 December 2025

Explore Basket

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.